Atlatl Advisers LLC Has $1.12 Million Stake in Intuitive Surgical, Inc. $ISRG

Atlatl Advisers LLC trimmed its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report) by 2.0% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,063 shares of the medical equipment provider’s stock after selling 43 shares during the quarter. Atlatl Advisers LLC’s holdings in Intuitive Surgical were worth $1,121,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. Chilton Capital Management LLC raised its position in Intuitive Surgical by 614.3% in the 1st quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 43 shares during the last quarter. Elite Financial Inc. purchased a new stake in Intuitive Surgical in the 1st quarter valued at $26,000. LFA Lugano Financial Advisors SA purchased a new stake in Intuitive Surgical in the 1st quarter valued at $30,000. TD Capital Management LLC raised its position in Intuitive Surgical by 300.0% in the 1st quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock valued at $30,000 after buying an additional 45 shares during the last quarter. Finally, 1248 Management LLC purchased a new stake in Intuitive Surgical in the 1st quarter valued at $30,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In related news, Director Amy L. Ladd sold 335 shares of Intuitive Surgical stock in a transaction dated Thursday, September 4th. The stock was sold at an average price of $440.69, for a total value of $147,631.15. Following the completion of the sale, the director owned 739 shares of the company’s stock, valued at approximately $325,669.91. This trade represents a 31.19% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, insider Gary S. Guthart sold 29,360 shares of Intuitive Surgical stock in a transaction dated Friday, August 29th. The stock was sold at an average price of $472.49, for a total value of $13,872,306.40. Following the completion of the sale, the insider directly owned 19,827 shares of the company’s stock, valued at approximately $9,368,059.23. This trade represents a 59.69% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 40,724 shares of company stock valued at $19,500,332. 0.70% of the stock is currently owned by insiders.

Analysts Set New Price Targets

A number of equities research analysts recently commented on the company. Royal Bank Of Canada set a $625.00 price target on Intuitive Surgical and gave the company an “outperform” rating in a research report on Wednesday. Hsbc Global Res raised Intuitive Surgical to a “strong-buy” rating in a research report on Thursday. Wall Street Zen raised Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Sunday. Evercore ISI lowered their price target on Intuitive Surgical from $535.00 to $450.00 and set an “in-line” rating for the company in a research report on Tuesday, October 7th. Finally, Mizuho set a $575.00 target price on Intuitive Surgical in a research report on Wednesday. One analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus target price of $602.32.

View Our Latest Analysis on ISRG

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock opened at $546.51 on Friday. Intuitive Surgical, Inc. has a 1 year low of $425.00 and a 1 year high of $616.00. The firm has a market cap of $195.91 billion, a PE ratio of 72.29, a P/E/G ratio of 5.45 and a beta of 1.61. The stock has a fifty day moving average price of $458.09 and a 200-day moving average price of $497.29.

Intuitive Surgical (NASDAQ:ISRGGet Free Report) last announced its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.99 by $0.41. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The firm had revenue of $2.51 billion during the quarter, compared to analyst estimates of $2.41 billion. During the same period last year, the firm posted $1.84 EPS. The business’s revenue was up 22.9% compared to the same quarter last year. As a group, equities analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Intuitive Surgical Company Profile

(Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Featured Stories

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report).

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.